PHOSPHA 250 NEUTRAL
NDC 64980-729, Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-729
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-729 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS852 mg/1
- POTASSIUM PHOSPHATE, MONOBASIC155 mg/1
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE130 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-729-01 | 64980072901 | 100 TABLET in 1 BOTTLE (64980-729-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9432adfc-6add-4ab4-ae93-2e2daf348be2NADAC price for package 64980072901
GET /v1/drugs/nadac/64980072901
Use it
Look up 64980-729 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-729 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-729. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.